To determine whether this uptake is characteristic of LSCs or both LSCs and HSCs, we isolated CD34-positive cells from bone marrow of five CML patients and categorized them immunophenotypically into CD38−/CD26+ LSCs and CD38−/CD26− HSCs. This evidence concerns the gene CD38 and chronic myelogenous leukemia, BCR-ABL1 positive.